Search Results - "Harst, P van der"

Refine Results
  1. 1

    The single-cell eQTLGen consortium by van der Wijst, Mgp, de Vries, D H, Groot, H E, Trynka, G, Hon, C C, Bonder, M J, Stegle, O, Nawijn, M C, Idaghdour, Y, van der Harst, P, Ye, C J, Powell, J, Theis, F J, Mahfouz, A, Heinig, M, Franke, L

    Published in eLife (09-03-2020)
    “…In recent years, functional genomics approaches combining genetic information with bulk RNA-sequencing data have identified the downstream expression effects…”
    Get full text
    Journal Article
  2. 2

    The fibrosis marker galectin-3 and outcome in the general population by de Boer, R. A., van Veldhuisen, D. J., Gansevoort, R. T., Muller Kobold, A. C., van Gilst, W. H., Hillege, H. L., Bakker, S. J. L., van der Harst, P.

    Published in Journal of internal medicine (01-07-2012)
    “…  de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJL, van der Harst P (University of Groningen). The…”
    Get full text
    Journal Article
  3. 3

    Telomere length loss due to smoking and metabolic traits by Huzen, J., Wong, L. S. M., Veldhuisen, D. J., Samani, N. J., Zwinderman, A. H., Codd, V., Cawthon, R. M., Benus, G. F. J. D., Horst, I. C.C., Navis, G., Bakker, S. J. L., Gansevoort, R. T., Jong, P. E., Hillege, H. L., Gilst, W. H., Boer, R. A., Harst, P.

    Published in Journal of internal medicine (01-02-2014)
    “…Objectives Human age‐dependent telomere attrition and telomere shortening are associated with several age‐associated diseases and poorer overall survival. The…”
    Get full text
    Journal Article
  4. 4

    Association between anxiety but not depressive disorders and leukocyte telomere length after 2 years of follow-up in a population-based sample by Hoen, P W, Rosmalen, J G M, Schoevers, R A, Huzen, J, van der Harst, P, de Jonge, P

    Published in Psychological medicine (01-04-2013)
    “…Telomere length is considered an emerging marker of biological aging. Depression and anxiety are associated with excess mortality risk but the mechanisms…”
    Get more information
    Journal Article
  5. 5

    Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women by Siland, J E, Nguyen, B O, de With, R R, Van Gelder, I C, van der Harst, P, Rienstra, M

    Published in PloS one (18-02-2021)
    “…Limited causal evidence is available on the relationship between body mass index (BMI) and atrial fibrillation (AF) progression. Sex differences have been…”
    Get full text
    Journal Article
  6. 6

    Diagnostic performance of semi-quantitative and quantitative stress CMR perfusion analysis: a meta-analysis by van Dijk, R, van Assen, M, Vliegenthart, R, de Bock, G H, van der Harst, P, Oudkerk, M

    “…Stress cardiovascular magnetic resonance (CMR) perfusion imaging is a promising modality for the evaluation of coronary artery disease (CAD) due to high…”
    Get full text
    Journal Article
  7. 7

    Vitamin D biology in heart failure: molecular mechanisms and systematic review by Meems, Laura M G, van der Harst, P, van Gilst, W H, de Boer, R A

    Published in Current drug targets (01-01-2011)
    “…Vitamin D has recently been suggested as an important mediator of blood pressure and cardiovascular disease, including heart failure. In patient with heart…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Angiotensin II Type 2 Receptor Vasoactivity in Internal Mammary Arteries of Patients With Coronary Artery Disease by Wal, R. M. A van de, Harst, P van der, Wagenaar, L J, Wassmann, S, Morshuis, W J, Nickenig, G, Buikema, H, Plokker, H W. M, van Veldhuisen, D J, van Gilst, W H, Voors, A A

    Published in Journal of cardiovascular pharmacology (01-10-2007)
    “…BACKGROUND:Several animal studies suggested that the angiotensin II type 2 (AT2) receptor subtype mediates vasodilation, yet the results in human arteries are…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    A primer in artificial intelligence in cardiovascular medicine by Benjamins, J. W., Hendriks, T., Knuuti, J., Juarez-Orozco, L. E., van der Harst, P.

    Published in Netherlands heart journal (01-09-2019)
    “…Driven by recent developments in computational power, algorithms and web-based storage resources, machine learning (ML)-based artificial intelligence (AI) has…”
    Get full text
    Journal Article
  15. 15

    Association of recognized and unrecognized myocardial infarction with depressive and anxiety disorders in 125,988 individuals: A report of the LifeLines cohort study by Roest, A., Iozzia, G., de Miranda Azevedo, R., van der Harst, P., Rosmalen, J., de Jonge, P.

    Published in Journal of psychosomatic research (01-06-2022)
    “…Background No previous study examined the role of recognition of myocardial infarction (MI) and the presence of affective disorders in a large population…”
    Get full text
    Journal Article
  16. 16

    Novel endotypes in heart failure: effects on guideline-directed medical therapy by Tromp, J, Ouwerkerk, W, Demissei, B G, Anker, S D, Cleland, J G, Dickstein, K, Filippatos, G, van der Harst, P, Hillege, H L, Lang, C C, Metra, M, Ng, L L, Ponikowski, P, Samani, N J, van Veldhuisen, D J, Zannad, F, Zwinderman, A H, Voors, A A, van der Meer, P

    Published in European heart journal (21-12-2018)
    “…We sought to determine subtypes of patients with heart failure (HF) with a distinct clinical profile and treatment response, using a wide range of biomarkers…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Genetic loci influencing kidney function and chronic kidney disease by Penninx, Brenda W, Waeber, Gerard, Prokopenko, Inga, Waterworth, Dawn, Dimkovic, Nada, Snieder, Harold, Shuldiner, Alan R, Ferrucci, Luigi, Gale, Daniel P, Dockrell, Mark, Swaminathan, Ramasamyiyer, Maréchal, Céline, Loos, Ruth J F, Peltonen, Leena, Abecasis, Goncalo R, Sanna, Serena, de Jong, Paul E, Ebrahim, Shah, Smit, Johannes H, Connell, John M C, Floege, Jurgen, Melander, Olle, Perucha, Esperanza, Seelen, Marc A J, Spector, Timothy D, Ahmadi, Kourosh R, Li, Yun, Mooser, Vincent, Schlessinger, David, Beckmann, Jacqui, Hepkema, Bouke G, Ubink-Veltmaat, Lielith J, Bakker, Stephan J L, Cook, H Terence, Vollenweider, Peter, Eggermann, Thomas, Sjögren, Marketa, Schalling, Martin, Jarvelin, Marjo-Riitta, Lightstone, Liz, Kooner, Jaspal S, Caulfield, Mark J, Dikkeschei, Lambert D, Farrall, Martin, Hedblad, Bo, Zerres, Klaus, McCarthy, Mark I, Samani, Nilesh J, Ruokonen, Aimo, Nordfors, Louise, de Silva, Ranil, Johnson, Toby, Lapsley, Marta, Gansevoort, Ron T, Scott, James, Brown, Morris J, Navis, Gerjan, Han, Xijin, Sehmi, Joban S, Bochud, Murielle, Hypponen, Elina, Schlieper, Georg, Bilo, Henk J G, Luan, Jian'an, Deng, Guohong, Wallace, Chris, Sternberg, Michael J E, Wass, Mark N, Elliott, Paul, Lagou, Vasiliki, Kleefstra, Nanne, Stenvinkel, Peter, Wareham, Nicholas J, Devuyst, Olivier, van der Harst, Pim, Maxwell, Patrick H, Cotlarciuc, Ioana, Pouta, Anneli, Lord, Graham M, Tanaka, Toshiko, Hernandez-Fuentes, Maria, Roderick, Paul J, Zhang, Weihua, Soranzo, Nicole, Chambers, John C, Uda, Manuela, Forouhi, Nita G, van der Heide, Jaap J Homan, Dominiczak, Anna, Luttropp, Karin, Parsa, Afshin, Lawlor, Debbie A, Munroe, Patricia B, Smith, George Davey

    Published in Nature genetics (01-05-2010)
    “…Using genome-wide association, we identify common variants at 2p12-p13, 6q26, 17q23 and 19q13 associated with serum creatinine, a marker of kidney function (P…”
    Get full text
    Journal Article